Cardiometabolic News and Research

RSS

More high-risk patients with pulmonary embolism may benefit from surgical intervention

A new American Heart Association scientific statement suggests surgery be considered for more people with high-risk pulmonary embolism (PE).

23 Jan 2023

Research explores the utility of epigenetically predicted BMI

DNA methylation is an accurate predictor of current BMI and a poor predictor of future BMI.

18 Jan 2023

Researchers identify plasma metabolomic markers for the Mediterranean diet among pregnant women

A recent study identifies blood metabolomic markers and metabolite panels linked to the Mediterranean diet in pregnant women.

17 Jan 2023

Beverage fructose intake may lead to an abnormal cardiometabolic profile

A new study describes that fructose intake from sugar-sweetened beverages can cause cardiometabolic disorders. In contrast, fruit fructose was found to be good for cardiometabolic health.

16 Jan 2023

Mediterranean diet reduces dietary inflammation scores after six months

A new study looked at the effects of replacing the habitual diet with the Mediterranean diet for six months in older Australians.

12 Jan 2023

The same genetic factors may contribute to both cardiometabolic diseases and dementia

Being affected by several cardiometabolic diseases such as diabetes, heart disease and stroke, is linked to a greatly increased risk of dementia and Alzheimer's disease.

12 Jan 2023

What impact does short-term sleep restriction have on gut microbiome?

In a recent study published in the journal Scientific Reports, researchers in the United States examined the effects of sleep restriction on the composition of gut microbiota and intestinal permeability.

9 Jan 2023

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a multi-project drug discovery collaboration with Boehringer Ingelheim, one of the world-leading pharmaceutical companies developing innovative therapies for diseases with unsatisfactory treatments.

5 Jan 2023

Blood-based dietary signatures accurately predict both diet and risk of diseases

When it comes to studying food and diet, it's difficult to know what people are eating – let alone their risk of disease caused by what they eat.

15 Dec 2022

Caffeinated coffee consumption linked to lower risk of T2D among women with history of gestational diabetes

The prevalence of type 2 diabetes is projected to continue rising and one in three Singaporeans currently has a risk of developing diabetes in their lifetime. Several early-life cardiometabolic complications make identifying high-risk populations and application of diabetes preventive strategies paramount.

13 Dec 2022

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

For people ages 75 and older, age-related changes in general health and in the heart and blood vessels require consideration and likely modifications in how heart attacks and heart disease are treated, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

12 Dec 2022

Researchers identify micronutrient supplementation to reduce cardiovascular risk

Healthy diets are rich in antioxidants like amino acids, omega-3 fatty acids and vitamin C, but exactly how beneficial these micronutrients are for cardiovascular health has long been controversial.

6 Dec 2022

Troubled sleep may be linked to risk factors for type 2 diabetes

As the Christmas season starts to ramp up, University of South Australia researchers are reminding people to prioritise a good night's sleep as new research shows that a troubled sleep may be associated with risk factors for type 2 diabetes.

2 Dec 2022

Plant-based foods vs. animal-based foods

An editorial published in The American Journal of Cardiology describes how wrong food choices can impact health at individual and population levels. Also discussed in the editorial are the ethical implications of eating animal-based foods and measures to promote healthier diets.

29 Nov 2022

Gut microbial flavonoid catabolite reverses fatty liver disease in mice

Researchers report that a gut microbial catabolite could reduce the cardiometabolic disease burden in mice.

29 Nov 2022

How does quinoa affect the gut microbiome of men?

Although a high intake of whole grain foods reduces the risk of cardiometabolic diseases, obesity, type 2 diabetes, and certain types of cancers, the underlying mechanism behind this occurrence is unclear. Whole grain foods tend to be healthier due to their high dietary fiber and phytoconstituents, typically lost during refining.

28 Nov 2022

Survey: Two-thirds of European dietitians believe drinking coffee in moderation has clear health benefits

A new report by the European Federation of the Associations of Dietitians, supported by the Institute for Scientific Information on Coffee, has revealed that almost two-thirds (62%) of European dietitians believe drinking coffee in moderation has clear health benefits, with 86% agreeing that regular moderate intake can improve alertness and 69% agreeing that regular, moderate intake is associated with an improvement in overall sports performance.

22 Nov 2022

Honey improves key measures of health, including blood sugar and cholesterol levels

Researchers look to better understand the impact of honey on mitigating certain cardiometabolic risk factors.

20 Nov 2022

Lipid screening and dyslipidemia intervention in adolescence may stop atherosclerosis progression

Consistently elevated lipids and dyslipidemia in early life were associated with worsening subclinical atherosclerosis, but simulated lipid treatment in late adolescence stopped atherosclerosis progression, a paper published in Atherosclerosis concludes.

15 Nov 2022

Exercising in the afternoon or at night best for blood sugar control

The impact of breaks in sedentary time and timing of physical activity with insulin resistance and liver fat content.

6 Nov 2022